S
NVCR icon

SignatureFD’s NovoCure NVCR Stock Holding History

SignatureFD’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.77K Sell
645
-30
-4% -$454 ﹤0.01% 2648
2026
Q1 		$7.36K Sell
675
-80
-11% -$999 ﹤0.01% 2640
2025
Q4 		$9.76K Sell
755
-133
-15% -$1.71K ﹤0.01% 2444
2025
Q3 		$11.5K Sell
888
-74
-8% -$989 ﹤0.01% 2359
2025
Q2 		$17.1K Sell
962
-399
-29% -$6.95K ﹤0.01% 2120
2025
Q1 		$24.3K Buy
1,361
+130
+11% +$2.95K ﹤0.01% 1960
2024
Q4 		$36.7K Sell
1,231
-48
-4% -$1.02K ﹤0.01% 1736
2024
Q3 		$20K Sell
1,279
-365
-22% -$6.62K ﹤0.01% 2042
2024
Q2 		$28.2K Buy
1,644
+627
+62% +$11K ﹤0.01% 1801
2024
Q1 		$15.9K Buy
1,017
+201
+25% +$2.96K ﹤0.01% 2107
2023
Q4 		$12.2K Buy
816
+106
+15% +$1.42K ﹤0.01% 2165
2023
Q3 		$11.5K Buy
710
+182
+34% +$5.25K ﹤0.01% 2133
2023
Q2 		$21.9K Sell
528
-352
-40% -$21.9K ﹤0.01% 1839
2023
Q1 		$52.9K Sell
880
-92
-9% -$7.35K ﹤0.01% 1364
2022
Q4 		$71.3K Sell
972
-76
-7% -$5.72K ﹤0.01% 1175
2022
Q3 		$80K Sell
1,048
-507
-33% -$39.5K ﹤0.01% 1064
2022
Q2 		$108K Buy
1,555
+180
+13% +$13.6K ﹤0.01% 953
2022
Q1 		$114K Buy
1,375
+852
+163% +$62.8K ﹤0.01% 977
2021
Q4 		$39K Buy
523
+197
+60% +$19.8K ﹤0.01% 1449
2021
Q3 		$38K Sell
326
-119
-27% -$18K ﹤0.01% 1451
2021
Q2 		$99K Buy
445
+60
+16% +$11.7K ﹤0.01% 961
2021
Q1 		$51K Buy
385
+45
+13% +$7.12K ﹤0.01% 1164
2020
Q4 		$59K Buy
340
+49
+17% +$6.71K ﹤0.01% 1001
2020
Q3 		$32K Buy
291
+175
+151% +$14K ﹤0.01% 1173
2020
Q2 		$7K Hold
116
– – ﹤0.01% 1695
2020
Q1 		$8K Buy
116
+101
+673% +$7.98K ﹤0.01% 1555
2019
Q4 		$1K Buy
+15
New +$1.21K ﹤0.01% 2068

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

SignatureFD's NVCR Position: Q2 2026 in Review

SignatureFD reduced its NovoCure (NVCR) stake by 4.4% in Q2 2026, selling an estimated $454 and leaving 645 shares worth $9.77K. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

SignatureFD first reported a position in NVCR in Q4 2019 and has held it in 27 quarters since. The position peaked at $114K in Q1 2022. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • SignatureFD held 645 shares of NovoCure worth $9.77K as of Q2 2026.
  • SignatureFD sold 30 NovoCure shares in Q2 2026, an estimated $454.
  • NovoCure made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2648 holding.
  • SignatureFD first reported a position in NovoCure in Q4 2019 and has held it in 27 quarters since.
  • SignatureFD's NovoCure position peaked at $114K in Q1 2022.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.